Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[ConditionSearch] Anemia
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 … 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Next Last
#
NCTID/Status
Study
Last Changed
601
NCT03251664
Completed
Completed
Food Groups Associated With Anaemia in Pregnant Women
Conditions: Anemia; Dietary Habits; Food Habits
Intervention: Food Groups Consumed
Conditions: Anemia; Dietary Habits; Food Habits
Intervention: Food Groups Consumed
August 17, 2017
602
NCT01340404
Completed
Completed
Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy
Conditions: Sickle Cell Anemia; Cerebrovascular Accident
Intervention: Stem Cell Transplantation, Transfusion Program
Conditions: Sickle Cell Anemia; Cerebrovascular Accident
Intervention: Stem Cell Transplantation, Transfusion Program
December 2, 2016
603
NCT00631163
Completed
Completed
Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Chronic Anemia; Transfusional Hemosiderosis
Intervention: Deferasirox (ICL670)
Conditions: Chronic Anemia; Transfusional Hemosiderosis
Intervention: Deferasirox (ICL670)
November 15, 2016
604
NCT00046969
Completed
Completed
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
Conditions: Anemia; Cervical Cancer
Intervention: Epoetin Beta, Cisplatin, Brachytherapy, Radiation Therapy
Conditions: Anemia; Cervical Cancer
Intervention: Epoetin Beta, Cisplatin, Brachytherapy, Radiation Therapy
May 29, 2013
605
NCT00117234
Completed
Completed
Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia
Conditions: Congestive Heart Failure; Anemia
Intervention: Darbepoetin Alfa
Conditions: Congestive Heart Failure; Anemia
Intervention: Darbepoetin Alfa
December 2, 2010
606
NCT01105494
Completed
Completed
An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia
Conditions: Anemia
Intervention: Epoetin Beta [NeoRecormon]
Conditions: Anemia
Intervention: Epoetin Beta [NeoRecormon]
September 12, 2012
607
NCT01322841
Completed
Completed
Universal Screening for Tuberculosis and Anemia With the CHICA System
Conditions: Tuberculosis; Iron Deficiency Anemia
Intervention: CHICA Diagnosis Module, CHICA Placebo
Conditions: Tuberculosis; Iron Deficiency Anemia
Intervention: CHICA Diagnosis Module, CHICA Placebo
October 21, 2016
608
NCT00922883
Active, not recruiting
Active, not recruiting
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
Conditions: Anemia, Aplastic; Anemia, Hypoplastic; Thrombocytopenia
Intervention: Eltrombopag
Conditions: Anemia, Aplastic; Anemia, Hypoplastic; Thrombocytopenia
Intervention: Eltrombopag
March 11, 2019
609
NCT00668694
Completed
Completed
Iron Deficiency Anemia and Psychosocial Stimulation
Conditions: Iron Deficiency Anemia
Intervention: Stimulation
Conditions: Iron Deficiency Anemia
Intervention: Stimulation
May 27, 2018
610
NCT00035607
Completed
Completed
Chemotherapy Related Anemia
Conditions: Anemia; Non-Myeloid Malignancies
Intervention: Darbepoetin Alfa SC, Darbepoetin Alfa IV
Conditions: Anemia; Non-Myeloid Malignancies
Intervention: Darbepoetin Alfa SC, Darbepoetin Alfa IV
May 9, 2013
611
NCT00269958
Completed
Completed
A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery
Conditions: Anemia
Intervention: Epoetin Alfa
Conditions: Anemia
Intervention: Epoetin Alfa
May 16, 2011
612
NCT02624141
Terminated
Terminated
A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy
Conditions: Anemia
Intervention: Epoetin Beta
Conditions: Anemia
Intervention: Epoetin Beta
November 1, 2016
613
NCT03062501
Unknown status
Unknown status
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis
Conditions: Anemia, Sickle Cell; Anemia; Sickle-Cell, With Crisis
Intervention: Hydroxyurea
Conditions: Anemia, Sickle Cell; Anemia; Sickle-Cell, With Crisis
Intervention: Hydroxyurea
February 20, 2017
614
NCT00497471
Terminated
Terminated
RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants
Conditions: Malaria; Anemia
Intervention: Deltaprim (3.125 Mg Pyrimethamine Plus 25 Mg Dapsone), Iron (2 Mg/kg/daily)
Conditions: Malaria; Anemia
Intervention: Deltaprim (3.125 Mg Pyrimethamine Plus 25 Mg Dapsone), Iron (2 Mg/kg/daily)
July 5, 2007
615
NCT02608060
Terminated
Terminated
A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
Conditions: Anemia
Intervention: Epoetin Beta
Conditions: Anemia
Intervention: Epoetin Beta
November 1, 2016
616
NCT01425307
Terminated
Terminated
Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea
May 2, 2017
617
NCT02286154
Recruiting
Recruiting
Therapeutic Response Evaluation and Adherence Trial (TREAT)
Conditions: Anemia, Sickle Cell
Intervention: Hydroxyurea
Conditions: Anemia, Sickle Cell
Intervention: Hydroxyurea
August 22, 2019
618
NCT01145638
Completed
Completed
A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)
Conditions: Non-myeloid Malignancies; Chemotherapy Induced Anaemia
Intervention: Iron Isomaltoside 1000, Iron Sulphate
Conditions: Non-myeloid Malignancies; Chemotherapy Induced Anaemia
Intervention: Iron Isomaltoside 1000, Iron Sulphate
November 2, 2015
619
NCT01166451
Completed
Completed
The Anemia Control Program: High or Low Iron Supplementation
Conditions: Iron Deficiency Anemia; Cognitive Development; Motor Development
Intervention: Low-iron Formula, High-iron Formula
Conditions: Iron Deficiency Anemia; Cognitive Development; Motor Development
Intervention: Low-iron Formula, High-iron Formula
October 17, 2011
620
NCT02774057
Unknown status
Unknown status
Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
Conditions: Iron Deficiency Anemia; Inflammatory Bowel Disease
Intervention: Captafer®, Iron Sulfate
Conditions: Iron Deficiency Anemia; Inflammatory Bowel Disease
Intervention: Captafer®, Iron Sulfate
January 24, 2017
621
NCT00111995
Completed
Completed
Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
Conditions: Chronic Renal Failure; Anemia
Intervention: Aranesp®
Conditions: Chronic Renal Failure; Anemia
Intervention: Aranesp®
August 7, 2008
622
NCT00937144
Withdrawn
Withdrawn
Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil
Conditions: Sickle Cell Anemia
Intervention: Viagra (Sildenafil), Placebo
Conditions: Sickle Cell Anemia
Intervention: Viagra (Sildenafil), Placebo
February 28, 2010
623
NCT01381094
Completed
Completed
42-Day Repeat Oral Dose Study of AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Conditions: Anemia; Kidney Disease
Intervention: AKB-6548, Placebo
Conditions: Anemia; Kidney Disease
Intervention: AKB-6548, Placebo
November 10, 2018
624
NCT01001871
Unknown status
Unknown status
Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Conditions: Anemia
Intervention: Sprinkles®, Vitamin/mineral Fortificant Without Iron
Conditions: Anemia
Intervention: Sprinkles®, Vitamin/mineral Fortificant Without Iron
October 26, 2009
625
NCT03413306
Recruiting
Recruiting
Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA
Conditions: Acquired Aplastic Anemia
Intervention: Eltrombopag, IST (ATG + CsA)
Conditions: Acquired Aplastic Anemia
Intervention: Eltrombopag, IST (ATG + CsA)
October 2, 2019
626
NCT03476330
Recruiting
Recruiting
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Conditions: Fanconi Anemia; Squamous Cell Carcinoma
Intervention: Quercetin (dietary Supplement)
Conditions: Fanconi Anemia; Squamous Cell Carcinoma
Intervention: Quercetin (dietary Supplement)
March 19, 2019
627
NCT01809314
Completed
Completed
An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy
Conditions: Anemia
Intervention: Epoetin Beta
Conditions: Anemia
Intervention: Epoetin Beta
July 8, 2016
628
NCT01235936
Completed
Completed
Safety and Efficacy Study for AKB-6548 in Subjects With Chronic Kidney Disease and Anemia
Conditions: Anemia; Kidney Disease
Intervention: AKB-6548
Conditions: Anemia; Kidney Disease
Intervention: AKB-6548
November 10, 2018
629
NCT01892202
No longer available
No longer available
A Non-Interventional Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Patients With Chronic Kidney Disease Not on Dialysis
Conditions: Anemia
Intervention: Cohort
Conditions: Anemia
Intervention: Cohort
October 26, 2016
630
NCT02075970
Active, not recruiting
Active, not recruiting
Optimized Erythropoietin (EPO) Treatment
Conditions: Neonatal Anemia
Intervention: Epoetin Alpha, Biotinylated Red Blood Cells
Conditions: Neonatal Anemia
Intervention: Epoetin Alpha, Biotinylated Red Blood Cells
February 20, 2019
631
NCT03010579
Unknown status
Unknown status
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
Conditions: Anemia; Lymphoma; Hematopoietic Stem Cell Transplantation
Intervention: Erythropoietin, Iron Supplementation
Conditions: Anemia; Lymphoma; Hematopoietic Stem Cell Transplantation
Intervention: Erythropoietin, Iron Supplementation
January 3, 2017
632
NCT00004492
Completed
Completed
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Clotrimazole, Hydroxyurea
Conditions: Sickle Cell Anemia
Intervention: Clotrimazole, Hydroxyurea
March 24, 2015
633
NCT01701531
Withdrawn
Withdrawn
Red Blood Cell Precursor Formulation to Determine Increased Production
Conditions: Anemia
Intervention: RBCPF
Conditions: Anemia
Intervention: RBCPF
May 4, 2016
634
NCT00802139
Completed
Completed
Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin
Conditions: Iron Deficiency Anemia
Intervention: Venoferrum(iron Sucrose), Bolgre (Iron Acetyl-transferase)
Conditions: Iron Deficiency Anemia
Intervention: Venoferrum(iron Sucrose), Bolgre (Iron Acetyl-transferase)
March 28, 2012
635
NCT00049985
Completed
Completed
August 6, 2009
636
NCT03653338
Recruiting
Recruiting
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Conditions: Sickle Cell Anemia; Beta-thalassemia Major; Diamond-blackfan Anemia
Intervention: CD3/CD19 Depleted Leukocytes, CD45RA Depleted Leukocytes, Hydroxyurea, Rituximab, Alemtuzumab, Fludarabine, Thiotepa
Conditions: Sickle Cell Anemia; Beta-thalassemia Major; Diamond-blackfan Anemia
Intervention: CD3/CD19 Depleted Leukocytes, CD45RA Depleted Leukocytes, Hydroxyurea, Rituximab, Alemtuzumab, Fludarabine, Thiotepa
February 28, 2019
637
NCT00303329
Completed
Completed
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
Conditions: Anemia; Hemosiderosis
Intervention: Deferasirox
Conditions: Anemia; Hemosiderosis
Intervention: Deferasirox
April 15, 2011
638
NCT00413894
Completed
Completed
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
Conditions: Anemia
Intervention: Methoxy Polyethylene Glycol-epoetin Beta [Mircera]
Conditions: Anemia
Intervention: Methoxy Polyethylene Glycol-epoetin Beta [Mircera]
January 17, 2016
639
NCT00442416
Terminated
Terminated
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
Conditions: Anemia
Intervention: Epoetin Alfa, Methoxy Polyethylene Glycol-epoetin Beta [Mircera]
Conditions: Anemia
Intervention: Epoetin Alfa, Methoxy Polyethylene Glycol-epoetin Beta [Mircera]
July 5, 2016
640
NCT03157804
Active, not recruiting
Active, not recruiting
Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A
Conditions: Fanconi Anemia
Intervention: IV Administration Of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs), Genetically Engineered Hematopoietic Stem/Progenitor Cells, Laboratory Biomarker Analysis, Filgrastim, Plerixafor, Bone Marrow Aspiration
Conditions: Fanconi Anemia
Intervention: IV Administration Of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs), Genetically Engineered Hematopoietic Stem/Progenitor Cells, Laboratory Biomarker Analysis, Filgrastim, Plerixafor, Bone Marrow Aspiration
July 1, 2019
641
NCT00118638
Completed
Completed
A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy
Conditions: Anemia; Non-Myeloid Malignancies
Intervention: Darbepoetin Alfa - 2.25 Mcg/kg, Darbepoetin Alfa - 500mcg
Conditions: Anemia; Non-Myeloid Malignancies
Intervention: Darbepoetin Alfa - 2.25 Mcg/kg, Darbepoetin Alfa - 500mcg
April 25, 2013
642
NCT00001398
Completed
Completed
Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia; Pancytopenia
Intervention: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
Conditions: Aplastic Anemia; Pancytopenia
Intervention: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
March 3, 2008
643
NCT03419780
Active, not recruiting
Active, not recruiting
SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia
Conditions: Postpartum Anemia Nos
Intervention: Blood Transfusion
Conditions: Postpartum Anemia Nos
Intervention: Blood Transfusion
July 16, 2019
644
NCT00229619
Completed
Completed
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic; Red-Cell Aplasia, Pure; Anemia, Diamond-Blackfan
Intervention: Rituximab
Conditions: Anemia, Aplastic; Red-Cell Aplasia, Pure; Anemia, Diamond-Blackfan
Intervention: Rituximab
August 20, 2018
645
NCT01555515
Terminated
Terminated
Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant
Conditions: Anemia; End Stage Renal Disease
Intervention: Implantation Of Autologous Skin Graft After Ex-vivo Treatment, Subcutan Implantation Of Autologus Skin Graft After Ex-vivo Treatment
Conditions: Anemia; End Stage Renal Disease
Intervention: Implantation Of Autologous Skin Graft After Ex-vivo Treatment, Subcutan Implantation Of Autologus Skin Graft After Ex-vivo Treatment
September 12, 2016
646
NCT03482076
Not yet recruiting
Not yet recruiting
Iron Deficiency Anemia in Childern With Liver Cirrhosis
Conditions: Iron Deficiency, Anaemia in Children; Liver Cirrhosis
Intervention: Transferrin Receptor Concentration
Conditions: Iron Deficiency, Anaemia in Children; Liver Cirrhosis
Intervention: Transferrin Receptor Concentration
March 23, 2018
647
NCT00120692
Completed
Completed
Treatment for Patients Suffering From Anemia Due to Chemotherapy
Conditions: Breast Cancer; Anemia
Intervention: Darbepoetin Alfa, Recombinant Human Erythropoietin
Conditions: Breast Cancer; Anemia
Intervention: Darbepoetin Alfa, Recombinant Human Erythropoietin
December 20, 2007
648
NCT00512564
Completed
Completed
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
Conditions: Sickle Cell Anemia; Sickle Cell Thalassemia
Intervention: Laboratory Analyses Of Iron Overload
Conditions: Sickle Cell Anemia; Sickle Cell Thalassemia
Intervention: Laboratory Analyses Of Iron Overload
August 25, 2011
649
NCT00579046
Withdrawn
Withdrawn
Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease
Conditions: Anemia; Chronic Obstructive Pulmonary Disease
Intervention: Darbepoetin Alfa
Conditions: Anemia; Chronic Obstructive Pulmonary Disease
Intervention: Darbepoetin Alfa
October 29, 2013
650
NCT01488305
Completed
Completed
Action Against Malnutrition Through Agriculture (AAMA) Plus MNP Study
Conditions: Anemia
Intervention: MNP (micro-nutrient Powders), AAMA Project Activities (HFP And IYCF BCC)
Conditions: Anemia
Intervention: MNP (micro-nutrient Powders), AAMA Project Activities (HFP And IYCF BCC)
August 22, 2019
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 … 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.